Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CHORD: Corticosteroids for Hand-Foot Syndrome in Liposomal Doxorubicin Therapy
NCT07362914Phase 3Recruiting
- Sponsor
- Fudan University
- Start
- Mar 2025
- Primary completion
- Jul 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of dexamethasone in hand-foot syndrome (HFS), sponsored by Fudan University. Started Mar 2025; status: recruiting.
02
Drugs
dexamethasone
03
Conditions
hand-foot syndrome (HFS)
Beyond the preview
Go deeper on NCT07362914.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07362914.